论文部分内容阅读
目的探讨临产孕妇凝血指标的变化特征,为预防产后出血提供科学依据。方法选取2014年5月—2015年5月商丘市妇幼保健院妇产科收治的临产孕妇230例,设为观察组,另随机抽取230例未孕妇女作为对照组,分析两组凝血指标的变化。结果与对照组相比,观察组凝血活酶时间(APTT)、凝血酶原时间(PT)明显降低,而纤维蛋白原(FIB)、纤维蛋白原降解产物(FDP)的指标明显升高,且差异有统计学意义(P<0.05);两组凝血酶时间(TT)的检测结果差异无统计学意义(P>0.05)。结论及时对临产孕妇进行凝血功能检测,可预防产妇产后并发症的发生,降低病死率,对保护母婴健康有重要的临床意义。
Objective To investigate the changes of coagulation index in pregnant women and provide a scientific basis for prevention of postpartum hemorrhage. Methods From May 2014 to May 2015, 230 pregnant women admitted to Obstetrics and Gynecology Hospital of Shangqiu Maternal and Child Health Hospital were enrolled as observation group. Another 230 pregnant women were randomly selected as the control group. Changes of coagulation index . Results Compared with the control group, APTT and PT were significantly decreased in the observation group, while the indexes of fibrinogen (FIB) and fibrinogen degradation products (FDP) were significantly increased in the observation group (P <0.05). There was no significant difference in the thrombin time (TT) between the two groups (P> 0.05). Conclusions The timely detection of clotting function of pregnant women may prevent the occurrence of postpartum complications and reduce the mortality of pregnant women, which has important clinical significance for the protection of maternal and infant health.